Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial

  • Salvatore Pucciarelli
  • , Antonino De Paoli
  • , Mario Guerrieri
  • , Giuseppe La Torre
  • , Isacco Maretto
  • , Francesco De Marchi
  • , Giovanna Mantello
  • , Maria Antonietta Gambacorta
  • , Vincenzo Canzonieri
  • , Donato Nitti
  • , Vincenzo Valentini
  • , Claudio Coco
  • University of Padua
  • IRCCS Centro di Riferimento Oncologico - Aviano PN
  • Marche Polytechnic University
  • Sapienza University
  • State Hospital

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

BACKGROUND: Transanal local excision has been suggested as an attractive approach for patients with rectal cancer who show a major clinical response after preoperative chemoradiotherapy. OBJECTIVE: To evaluate the impact of transanal local excision on the local recurrence of rectal cancer in patients who had a major clinical response after preoperative chemoradiotherapy. DESIGN: Sequential 2-stage phase II study for early efficacy. SETTING: Multicenter study. PATIENTS: Patients with clinical T3 or low-lying T2 rectal adenocarcinoma that showed a major clinical response after a preoperative chemoradiotherapy. Eligible patients underwent a full-thickness transanal local excision. According to their histopathology, the patients staged as ypT0-1 were observed, while the remaining patients were recommended to undergo a subsequent total mesorectal excision. MAIN OUTCOME MEASURES: A local recurrence rate of ≤5% was set as a successful rate for stopping the trial early after the first stage. RESULTS: The study group included 63 patients. Before chemoradiotherapy, patients were staged as clinical T3 (n = 42) and T2 (n = 21). After the local excision, 43 patients fulfilled the criteria to be observed with no further treatment. Nine of the remaining 20 patients for whom a subsequent total mesorectal excision was recommended refused surgery. Two of these patients who refused surgery had intraluminal local recurrence; both had a ypT2 tumor and underwent salvage surgery. The estimated cumulative 3-year overall survival, disease-free survival and local disease-free survival were 91.5% (95% CI: 75.9-97.2), 91.0% (95% CI: 77.0-96.6) and 96.9% (95% CI: 80.3-99.5), respectively. LIMITATIONS: The time of follow-up is still short and the sample size is limited. CONCLUSIONS: Our data suggest that local excision is a good option for patients with a major clinical response after chemoradiotherapy. A longer period of follow-up is required to confirm these findings.
Lingua originaleInglese
pagine (da-a)1349-56-1356
RivistaDISEASES OF THE COLON & RECTUM
Volume56
DOI
Stato di pubblicazionePubblicato - 2013

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

Keywords

  • Adenocarcinoma
  • Adult
  • Aged
  • Aged, 80 and over
  • Chemoradiotherapy
  • Digestive System Surgical Procedures
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Recurrence, Local
  • Rectal Neoplasms
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial'. Insieme formano una fingerprint unica.

Cita questo